Korea Arlico Pharm Co (XKRX:260660) YoY EBITDA Growth : 1,383.77% (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Korea Arlico Pharm Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Korea Arlico Pharm Co's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 1,383.77%.

Korea Arlico Pharm Co's EBITDA per Share for the three months ended in Sep. 2024 was ₩368.12.

Korea Arlico Pharm Co YoY EBITDA Growth Historical Data

The historical data trend for Korea Arlico Pharm Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Arlico Pharm Co YoY EBITDA Growth Chart

Korea Arlico Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

236.76

-41.99

2.77

46.68

-20.68

Korea Arlico Pharm Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial															-90.97	-246.58	-98.74	-138.13	1,383.77

Korea Arlico Pharm Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Korea Arlico Pharm Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(655.048	-	825.867)	/	\| 825.867 \|
=	-20.68 %

Korea Arlico Pharm Co's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(368.123	-	24.81)	/	\| 24.81 \|
=	1,383.77 %

Korea Arlico Pharm Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Korea Arlico Pharm Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Korea Arlico Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Arlico Pharm Co Ltd (XKRX:260660) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

7-21, Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR

Website

http://www.arlico.co.kr

Korea Arlico Pharm Co Ltd is engaged in the business of manufacturing and selling pharmaceuticals products. The company offers products in the area of the circulatory system, antiplatelet, muscle relaxants, diabetes, antibiotic and chemotherapy, allergy and respiratory disease, ointment, vitamin and health supplements, digestive system, and metabolic disease. It provides products in various forms such as tablets, capsules, gel, and cream.

Korea Arlico Pharm Co Headlines

No Headlines